Where No mAb's Gone Before
CellTherapy Firm Healthpoint Nabbed in $782M Acquisition
By Anette Breindl
Science Editor
Science Editor
Medical technology firm Smith & Nephew plc, of London, picked up Fort Worth, Texas-based cell therapy company Healthpoint Biotherapeutics for $782 million in cash. Healthpoint markets Collagenase Santyl ointment, and has a cell therapy product, HP802-247, in Phase III testing for wound healing.